K. Kingwell, Bacteriophage therapies re-enter clinical trials, Nature Reviews Drug Discovery, vol.14, issue.8, pp.515-521, 2015.
DOI : 10.1038/nrd4695

A. Wright, C. Hawkins, E. Anggård, and D. Harper, ; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-57, 2009.
DOI : 10.3201/eid0809.020063

S. Sarker, S. Sultana, and G. Reuteler, Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh, EBioMedicine, vol.4, pp.124-161, 2016.
DOI : 10.1016/j.ebiom.2015.12.023

T. Viertel, K. Ritter, and H. Horz, Viruses versus bacteria--novel approaches to phage therapy as a tool against multidrug-resistant pathogens, Journal of Antimicrobial Chemotherapy, vol.69, issue.9, pp.2326-2362, 2014.
DOI : 10.1093/jac/dku173

C. Loc-carrillo and S. Abedon, Pros and cons of phage therapy, Bacteriophage, vol.14, issue.2, pp.111-115, 2011.
DOI : 10.4161/bact.1.2.15680

D. Remick, Pathophysiology of Sepsis, The American Journal of Pathology, vol.170, issue.5, pp.1435-1479, 2007.
DOI : 10.2353/ajpath.2007.060872

L. Casey, R. Balk, and R. Bone, Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome, Annals of Internal Medicine, vol.119, issue.8, pp.771-779, 1993.
DOI : 10.7326/0003-4819-119-8-199310150-00001

J. Marshall, D. Foster, and J. Vincent, Diagnostic and Prognostic Implications of Endotoxemia in Critical Illness: Results of the MEDIC Study, The Journal of Infectious Diseases, vol.190, issue.3, pp.527-561, 2004.
DOI : 10.1086/422254

S. Opal, P. Scannon, and J. Vincent, Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS???Binding Protein in Patients with Severe Sepsis and Septic Shock, The Journal of Infectious Diseases, vol.180, issue.5, pp.1584-1593, 1999.
DOI : 10.1086/315093

P. Lepper, T. Held, E. Schneider, E. Bölke, H. Gerlach et al., Clinical implications of antibiotic-induced endotoxin release in septic shock, Intensive Care Medicine, vol.28, issue.7, pp.824-857, 2002.
DOI : 10.1007/s00134-002-1330-6

A. Simpson, S. Opal, and B. Angus, Differential Antibiotic???Induced Endotoxin Release in Severe Melioidosis, The Journal of Infectious Diseases, vol.181, issue.3, pp.1014-1023, 2000.
DOI : 10.1086/315306
URL : https://pure.uva.nl/ws/files/3194016/12433_87656y.pdf

J. Prins, M. Van-agtmael, E. Kuijper, S. Van-deventer, and P. Speelman, Antibiotic-Induced Endotoxin Release in Patients with Gram-Negative Urosepsis: A Double-Blind Study Comparing Imipenem and Ceftazidime, Journal of Infectious Diseases, vol.172, issue.3, pp.886-91, 1995.
DOI : 10.1093/infdis/172.3.886

T. Matsuda, T. Freeman, and D. Hilbert, Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model, Surgery, vol.137, issue.6, pp.639-685, 2005.
DOI : 10.1016/j.surg.2005.02.012

S. Hagens, A. Habel, U. Von-ahsen, A. Von-gabain, and U. Bläsi, Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage, Antimicrobial Agents and Chemotherapy, vol.48, issue.10, pp.3817-3839, 2004.
DOI : 10.1128/AAC.48.10.3817-3822.2004

E. Brzuszkiewicz, H. Bruggemann, and H. Liesegang, How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains, Proceedings of the National Academy of Sciences, vol.70, issue.8, pp.12879-84, 2006.
DOI : 10.1128/IAI.70.8.4406-4413.2002

N. Dufour, O. Clermont, L. Combe, and B. , clonal complex, Journal of Antimicrobial Chemotherapy, vol.71, issue.11, pp.3072-80, 2016.
DOI : 10.1093/jac/dkw253

N. Dufour, L. Debarbieux, M. Fromentin, and J. Ricard, Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages*, Critical Care Medicine, vol.43, issue.6, pp.190-198, 2015.
DOI : 10.1097/CCM.0000000000000968

M. Henry, R. Lavigne, and L. Debarbieux, Predicting In Vivo Efficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections, Antimicrobial Agents and Chemotherapy, vol.57, issue.12, pp.5961-5969, 2013.
DOI : 10.1128/AAC.01596-13

W. Craig and S. Ebert, Killing and regrowth of bacteria in vitro: a review, Scand J Infect Dis Suppl, vol.74, pp.63-70, 1990.

R. Moore, P. Lietman, and C. Smith, Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory Concentration, Journal of Infectious Diseases, vol.155, issue.1, pp.93-102, 1987.
DOI : 10.1093/infdis/155.1.93

J. Turnidge, The Pharmacodynamics of ??Lactams, Clinical Infectious Diseases, vol.27, issue.1, pp.10-22, 1998.
DOI : 10.1086/514622

S. Zelenitsky, G. Harding, S. Sun, K. Ubhi, and R. Ariano, Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis, Journal of Antimicrobial Chemotherapy, vol.52, issue.4, pp.668-74, 2003.
DOI : 10.1093/jac/dkg403

F. Taccone, M. Hites, M. Beumier, S. Scolletta, and F. Jacobs, Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock, Current Infectious Disease Reports, vol.49, issue.Suppl C, pp.406-421, 2011.
DOI : 10.1007/s11908-011-0203-y

L. Debarbieux, D. Leduc, and D. Maura, Lung Infections, The Journal of Infectious Diseases, vol.201, issue.7, pp.1096-104, 2010.
DOI : 10.1086/651135
URL : https://hal.archives-ouvertes.fr/pasteur-01425464

A. Leber, 14 tests to assess bactericidal activity, Leber AL. Clinical Microbiology Procedures Handbook, 2016.

K. Lewis, Persister Cells, Annual Review of Microbiology, vol.64, issue.1, pp.357-72, 2010.
DOI : 10.1146/annurev.micro.112408.134306

H. Hanberger, L. Nilsson, M. Nilsson, and R. Maller, Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC, European Journal of Clinical Microbiology & Infectious Diseases, vol.18, issue.Supplement D, pp.927-961, 1991.
DOI : 10.1093/jac/12.suppl_D.1

A. Bruttin and H. Brüssow, Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy, Antimicrobial Agents and Chemotherapy, vol.49, issue.7, pp.2874-2882, 2005.
DOI : 10.1128/AAC.49.7.2874-2878.2005

S. Mccallin, A. Sarker, S. Barretto, and C. , Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects, Virology, vol.443, issue.2, pp.187-96, 2013.
DOI : 10.1016/j.virol.2013.05.022

R. Mi?dzybrodzki, J. Borysowski, and B. Weber-d?browska, Clinical Aspects of Phage Therapy, Adv Virus Res, vol.83, pp.73-121, 2012.
DOI : 10.1016/B978-0-12-394438-2.00003-7

P. Miernikiewicz, K. D?browska, and A. Piotrowicz, T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production, PLoS ONE, vol.222, issue.1, p.71036, 2013.
DOI : 10.1371/journal.pone.0071036.t004
URL : http://doi.org/10.1371/journal.pone.0071036

N. Dufour, M. Henry, J. Ricard, and L. Debarbieux, Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro, Frontiers in Microbiology, vol.4, issue.437, p.1029, 2016.
DOI : 10.1371/journal.pone.0004944

R. Young, Phage lysis: Three steps, three choices, one outcome, Journal of Microbiology, vol.176, issue.3, pp.243-58, 2014.
DOI : 10.1007/s12275-014-4087-z
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012431

R. Wright, S. Makover, and E. Telep, Ro 13-9904: Affinity for penicillin binding proteins and effect on cell wall synthesis., The Journal of Antibiotics, vol.34, issue.5, pp.590-595, 1981.
DOI : 10.7164/antibiotics.34.590

I. Gould and F. Mackenzie, The response of Enterobacteriaceae to beta-lactam antibiotics--'round forms, filaments and the root of all evil', Journal of Antimicrobial Chemotherapy, vol.40, issue.4, pp.495-504, 1997.
DOI : 10.1093/jac/40.4.495

R. Fontana, G. Cornaglia, M. Ligozzi, and A. Mazzariol, The final goal: penicillin-binding proteins and the target of cephalosporins, Clinical Microbiology and Infection, vol.6, issue.3, pp.34-40, 2000.
DOI : 10.1111/j.1469-0691.2000.tb02038.x

A. Lindner, R. Madden, A. Demarez, E. Stewart, and F. Taddei, Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation, Proceedings of the National Academy of Sciences, vol.188, issue.1, pp.3076-81, 2008.
DOI : 10.1128/JB.188.1.339-342.2006

N. Bednarska, J. Schymkowitz, F. Rousseau, and J. Van-eldere, Protein aggregation in bacteria: the thin boundary between functionality and toxicity, Microbiology, vol.159, issue.Pt_9, pp.1795-806, 2013.
DOI : 10.1099/mic.0.069575-0

Z. Drulis-kawa, G. Majkowska-skrobek, B. Maciejewska, A. Delattre, and R. Lavigne, Learning from Bacteriophages - Advantages and Limitations of Phage and Phage-Encoded Protein Applications, Current Protein and Peptide Science, vol.13, issue.8, pp.699-722, 2012.
DOI : 10.2174/138920312804871193

A. Chevallereau, B. Blasdel, D. Smet, and J. , Next-Generation ?-omics? Approaches Reveal a Massive Alteration of Host RNA Metabolism during Bacteriophage Infection of Pseudomonas aeruginosa, PLOS Genetics, vol.102, issue.7, p.1006134, 2016.
DOI : 10.1371/journal.pgen.1006134.s010
URL : https://hal.archives-ouvertes.fr/pasteur-01350678

M. De-paepe and F. Taddei, Viruses' Life History: Towards a Mechanistic Basis of a Trade-Off between Survival and Reproduction among Phages, PLoS Biology, vol.258, issue.7, p.193, 2006.
DOI : 10.1371/journal.pbio.0040193.t001
URL : https://hal.archives-ouvertes.fr/inserm-00080125

B. Cairns, A. Timms, V. Jansen, I. Connerton, and R. Payne, Quantitative Models of In Vitro Bacteriophage?Host Dynamics and Their Application to Phage Therapy, PLoS Pathogens, vol.172, issue.1, p.1000253, 2009.
DOI : 10.1371/journal.ppat.1000253.t003

M. De-paepe, L. Tournier, E. Moncaut, O. Son, P. Langella et al., Carriage of ? Latent Virus Is Costly for Its Bacterial Host due to Frequent Reactivation in Monoxenic Mouse Intestine, PLOS Genetics, vol.77, issue.2, p.1005861, 2016.
DOI : 10.1371/journal.pgen.1005861.s006

K. Gupta, T. Hooton, and K. Naber, International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases, Clinical Infectious Diseases, vol.52, issue.5, pp.103-123, 2011.
DOI : 10.1093/cid/ciq257

R. Dellinger, M. Levy, and A. Rhodes, Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.580-637, 2013.
DOI : 10.1097/CCM.0b013e31827e83af

P. Tamma, S. Cosgrove, and L. Maragakis, Combination Therapy for Treatment of Infections with Gram-Negative Bacteria, Clinical Microbiology Reviews, vol.25, issue.3, pp.450-70, 2012.
DOI : 10.1128/CMR.05041-11

A. Craig, J. Mai, S. Cai, and S. Jeyaseelan, Neutrophil Recruitment to the Lungs during Bacterial Pneumonia, Infection and Immunity, vol.77, issue.2, pp.568-75, 2009.
DOI : 10.1128/IAI.00832-08
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632043

S. Blot, F. Pea, and . J. Lipman, The effect of pathophysiology on pharmacokinetics in the critically ill patient ? Concepts appraised by the example of antimicrobial agents, Advanced Drug Delivery Reviews, vol.77, pp.3-11, 2014.
DOI : 10.1016/j.addr.2014.07.006